Glyceollin Transport, Metabolism, and Effects on P-Glycoprotein Function in Caco-2 Cells

다국어 초록 (Multilingual Abstract)

Glyceollins are phytoalexins produced in soybeans from their isoflavone precursor daidzein. Their impressive anticancer and glucose normalization effects in rodents have generated interest in their therapeutic potential. The aim of the present studies was to begin to understand glyceollin intestinal transport and metabolism, and their potential effects on P-glycoprotein (Pgp) in Caco-2 cells. At 10 and 25 lM, glyceollin permeability was 2.4 – 0.16 · 10- 4 cm/sec and 2.1 – 0.15 · 10- 4 cm/sec, respectively, in the absorptive direction. Basolateral to apical permeability at 25 lM was 1.6 – 0.10 · 10- 4 cm/sec. Results suggest high absorption potential of glyceollin by a passive-diffusion-dominated mechanism. A sulfate conjugate at the phenolic hydroxyl position was observed following exposure to Caco-2 cells. In contrast to verapamil inhibition of the net secretory permeability of rhodamine 123 (R123) and its enhancement of calcein AM uptake into Caco-2 cells, neither glyceollin nor genistein inhibited Pgp (MDR1; ABCB1) up to 300 lM. There was no significant change in MDR1 mRNA expression, Pgp protein expression, or R123 transport in cells exposed to glyceollin or genistein for 24 h up to 100 lM. Collectively, these results suggest that glyceollin has the potential to be well absorbed, but that, similar to the isoflavone genistein, its absorption may be reduced substantially by intestinal metabolism; further, they indicate that glyceollin does not appear to alter Pgp function in Caco-2 cells.

참고문헌 (Reference)

1 Saksena S, "Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice" 300 : G1115-G1123, 2011

2 Benet LZ, "Transporter-enzyme interactions : implications for predicting drug-drug interactions from in vitro data" 4 : 393-398, 2003

3 Romsicki Y, "The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter" 38 : 6887-6896, 1999

4 Grace G.L. Yue, "The Role of Turmerones on Curcumin Transportation and P-Glycoprotein Activities in Intestinal Caco-2 Cells" 한국식품영양과학회 15 (15): 242-252, 2012

5 Tian XJ, "Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model" 367 : 58-64, 2009

6 van der Sandt IC, "Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1and Caco-2 cell lines" 11 : 207-214, 2000

7 Quadri SS, "Screening and identification of glyceollins and their metabolites by electrospray ionization tandem mass spectrometry with precursor ion scanning" 85 : 1727-1733, 2013

8 Gannon MK, "Rhodamine inhibitors of P-glycoprotein, an amide/thioamide ‘‘switch’’ for ATPase activity" 52 : 3328-3341, 2009

9 Im SS, "Regulation of glucose transporter type 4 isoform gene expression in muscle and adipocytes" 59 : 134-135, 2007

10 Tiberghien F, "Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay" 7 : 568-578, 1996

11 Shapiro AB, "Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities" 250 : 130-137, 1997

12 Marzolini C, "Polymorphisms in human MDR1 (P-glycoprotein), recent advances and clinical relevance" 75 : 13-33, 2004

13 Burow ME, "Phytochemical glyceollins, isolated from soy, mediate antihormonal effects through estrogen receptor alpha and beta" 86 : 1750-1758, 2001

14 Davies B, "Physiological parameters in laboratory animals and humans" 10 : 1093-1095, 1993

15 Lautier D, "Multidrug resistance mediated by the multidrug resistance protein(MRP)gene" 52 : 967-977, 1996

16 Annese V, "Multidrug resistance 1 gene in inflammatory bowel disease, a metaanalysis" 12 : 3636-3644, 2006

17 Ho GT, "Multidrug resistance 1 gene (Pglycoprotein 170), an important determinant in gastrointestinal disease?" 52 : 759-766, 2003

18 Chen KG, "Molecular pathways, Regulation and therapeutic implications of multidrug resistance" 18 : 1863-1869, 2012

19 Melani R, "Modulation of cystic fibrosis transmembrane conductance regulator(CFTR)activity and genistein binding by cytosolic pH" 285 : 41591-41596, 2010

20 Chen J, "Metabolism of flavonoids via enteric recycling, Role of intestinal disposition" 304 : 1228-1235, 2003

21 Langmann T, "Loss of detoxification in inflammatory bowel disease, dysregulation of pregnane X receptor target genes" 127 : 26-40, 2004

22 Castro AF, "Inhibition of drug transport by genistein in multidrug-resistant cells expressing P-glycoprotein" 53 : 89-93, 1997

23 Ayers AR, "Hostpathogen interactions. IX. Quantitative assays of elicitor activity and characterization of the elicitor present in the extracellular medium of cultures of Phytophthora megasperma var. sojae" 57 : 751-759, 1976

24 Boue´ SM, "Glyceollins, soy isoflavone phytoalexins, improve oral glucose disposal by stimulating basal and insulin-mediated uptake mediated by glucose transporters in adipocytes" 60 : 6376-6382, 2012

25 Park S, "Glyceollin-containing fermented soybeans improve glucose homeostasis in diabetic mice" 28 : 204-211, 2012

26 Zimmermann MC, "Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy" 332 : 35-45, 2010

27 Versantvoort CHM, "Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells" 68 : 939-946, 1993

28 Pe´triz J, "Flow cytometric analysis of Pglycoprotein function using rhodamine 123" 11 : 1124-1130, 1997

29 Okura T, "Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells" 33 : 255-259, 2010

30 Taur JS, "Effects of dietary flavonoids on the transport of cimetidine via P-glycoprotein and cationic transporters in Caco-2 and LLC-PK1 cell models" 38 : 1536-1550, 2008

31 Martel F, "Effect of polyphenols on the intestinal and placental transport of some bioactive compounds" 23 : 47-64, 2010

32 Lin JH, "Drug-drug interaction mediated by inhibition and induction of P-glycoprotein" 55 : 53-, 2003

33 Chen J, "Disposition of flavonoids via recycling, comparison of intestinal versus hepatic disposition" 33 : 1777-1784, 2005

34 Wang SWJ, "Disposition of flavonoids via enteric recycling, structural effects and lack of correlations between in vitro and in situ metabolic properties" 34 : 1837-1848, 2006

35 Takara K, "Digoxin upregulates MDR1 in human colon carcinoma Caco-2 cells" 292 : 190-194, 2002

36 Mease K, "Differential selectivity of efflux transporter inhibitors in Caco-2 and MDCK-MDR1monolayers, a strategy to assess the interaction of a new chemical entity with P-gp, BCRP, and MRP2" 101 : 1888-1897, 2012

37 Blokzijl H, "Decreased P-glycoprotein(Pgp/MDR1)expression in inflamed human intestinal epithelium is independent of PXR protein levels" 13 : 710-720, 2007

38 Artursson P, "Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial(Caco-2)cells" 175 : 880-885, 1991

39 Zhu W, "Breast cancer resistance protein(BCRP)and sulfotransferase contribute significantly to the disposition of genestien in the mouse intestine" 12 : 525-536, 2010

40 Yang Z, "Breast cancer resistance protein (ABCG2) determines distribution of genistein phase II metabolites, reevaluation of the roles of ABCG2 in the disposition of genistein" 40 : 1883-1893, 2012

41 A ´ lvarez AI, "Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice" 39 : 2008-2012, 2011

42 Salvo VA, "Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis" 12 : 7159-7164, 2006

43 Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT method" 25 : 402-408, 2001

44 Hollman PCH, "Absorption, metabolism and health effects of dietary flavonoids in man" 51 : 305-310, 1997

45 Chen J, "Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2model" 55 : 159-169, 2005

46 Liu Y, "Absorption and metabolism of flavonoids in the caco-2 cell culture model and in a perfused rat intestinal model" 30 : 370-377, 2002

47 Walle T, "Absorption and metabolism of flavonoids" 36 : 829-837, 2004